LSM2 and central nervous system cancer: Upon isolating cells based on risk score gene expression levels, we found that cells with higher LSM2 expression had lower immune scores, while those with elevated OSMR expression had higher immune scores, reinforcing the roles of LSM2 and OSMR in glioma immunity (Figure 7C–H).